Manufacturers Life Insurance Company, The Zentalis Pharmaceuticals, Inc. Transaction History
Manufacturers Life Insurance Company, The
- $103 Billion
- Q1 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 131,815 shares of ZNTL stock, worth $458,716. This represents 0.0% of its overall portfolio holdings.
Number of Shares
131,815
Previous 116,894
12.76%
Holding current value
$458,716
Previous $1.77 Million
17.34%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding ZNTL
# of Institutions
142Shares Held
76.3MCall Options Held
68.2KPut Options Held
2.3K-
Matrix Capital Management Company, LP Waltham, MA14MShares$48.6 Million2.04% of portfolio
-
Eventide Asset Management, LLC Boston, MA11.6MShares$40.3 Million2.94% of portfolio
-
Black Rock Inc. New York, NY4.65MShares$16.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.4MShares$15.3 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.85MShares$13.4 Million0.01% of portfolio
About Zentalis Pharmaceuticals, Inc.
- Ticker ZNTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,983,600
- Market Cap $198M
- Description
- Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...